ኤፒአይ |
የምርት ስም |
ጉዳይ ቁጥር |
ምደባ |
HQC23838 |
Sulfapyridine |
144-83-2 |
አንቲባዮቲክስ |
PF-07321332 (የፓክስሎቪድ መድኃኒት) |
(1R,2S,5S)-6,6-ዲሜቲል-3-አዛ-ቢሲክሎ[3.1.0]ሄክሳኔ-2-ካርቦክሲሊክ አሲድ ሜቲል ኤስተር ሃይድሮክሎራይድ |
565456-77-1 |
ኮቪድ 19 |
PF-07321333 (የፓክስሎቪድ መድኃኒት) |
ኤል-ቫሊን፣ 3-ሜቲኤል-ኤን- (trifluoroacetyl)- (9CI) |
666832-71-9 |
ኮቪድ 19 |
PF-07321334 (የፓክስሎቪድ መድኃኒት) |
(αS,3S)-α-[(tert-Butyloxycarbonyl) aMino] -2-oxo-3-pyrrolidinepropanoic አሲድ ሜቲል ኤስተር |
328086-60-8 |
ኮቪድ 19 |
PF-07321335 (የፓክስሎቪድ መድኃኒት) |
6,6-Dimethyl-3-azabicyclo [3.1.0] hexane |
943516-54-9 |
ኮቪድ 19 |
PF-07321336 (የፓክስሎቪድ መድኃኒት) |
ዲሜቲል (2S,4R) -2- (ቦክ-አሚኖ) -4- (ሲያኖሜቲል) ፔንታኔዲዮት |
328086-57-3 |
ኮቪድ 19 |
PF-07321337 (የፓክስሎቪድ መድኃኒት) |
1- (3-Dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride |
25952-53-8 እ.ኤ.አ |
ኮቪድ 19 |
PF-07321338 (የፓክስሎቪድ መድኃኒት) |
2-ሃይድሮክሲፒሪዲን 1-ኦክሳይድ (HOPO) |
13161-30-3 |
ኮቪድ 19 |
PF-07321339 (የፓክስሎቪድ መድኃኒት) |
ሊቲየም ሃይድሮክሳይድ |
1310-65-2 |
ኮቪድ 19 |
PF-07321340 (የፓክስሎቪድ መድኃኒት) |
1-[ቢስ (ዲሜቲላሚኖ) ሜቲልሊን] -1H-1,2,3-triazolo [4,5-b] pyridinium 3-oxide hexafluorophosphate (HATU) |
148893-10-1 |
ኮቪድ 19 |
apixaban |
አሴቲክ አሲድ፣ 2-ክሎሮ-2-[2- (4-ሜቶክሲፊኒል) hydrazinylidene]፣ ethyl ester |
27143-07-3 |
የካርዲዮቫስኩላር |
apixaban |
3-Morpholino-1- (4-nitrophenyl)-5,6-dihydropyridin-2 (1H) - አንድ |
545445-44-1 |
የካርዲዮቫስኩላር |
ሳኩቢትሪል |
LCZ696 |
1426129-50-1 |
የካርዲዮቫስኩላር |
ሳኩቢትሪል |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-ሜቲልፔንታኖይክ አሲድ |
1012341-50-2 |
የካርዲዮቫስኩላር |
ሳኩቢትሪል |
አአሁ377 |
149709-62-6 እ.ኤ.አ |
የካርዲዮቫስኩላር |
Ticagrelor |
2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy) ኤታኖል ኤል-ታታሪክ አሲድ |
376608-65-0 |
የካርዲዮቫስኩላር |
Ticagrelor |
(1R,2S)-2- (3,4-Difluorophenyl) ሳይክሎፕሮፓናሚኒየም (2R) -ሃይድሮክሲ (ፊኒል) ኤታኖት |
376608-71-8 |
የካርዲዮቫስኩላር |
Ticagrelor |
ሳይክሎፕሮፓናሚን, 2- (3,4-difluorophenyl)-(1R,2S) -(2R,3R) -2,3-dihydroxybutanedioate. |
220352-39-6 |
የካርዲዮቫስኩላር |
Ticagrelor |
4,6-dichloro-2-propylthiopyrimidine-5-አሚን |
145783-15-9 እ.ኤ.አ |
የካርዲዮቫስኩላር |
ኩዊናፕሪል |
(ኤስ) -1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic አሲድ |
74163-81-8 |
የካርዲዮቫስኩላር |
Rosuvastatin |
ዜድ-9፡ 4- (4-Fluorophenyl)-6-Isoropyl-2-[(N-methyl-N-methylsulfonyl)amino] pyrimidinyl-5-yl-formyl |
147118-37-4 |
የካርዲዮቫስኩላር |
Rosuvastatin |
Z-7: 4- (4-Fluorophenyl) -6-ኢሶፕሮፒል-2-[(ኤን-ሜቲኤል-ኤን-ሜቲልሱፎኒል) አሚኖ] ፒሪሚዲን-5-ኤል-ሜታኖል |
147118-36-3 እ.ኤ.አ |
የካርዲዮቫስኩላር |
ሪቫሮክሳባን |
4- (4-Aminophenyl) ሞርፎሊን-3-አንድ |
438056-69-0 |
የካርዲዮቫስኩላር |
ሪቫሮክሳባን |
5-Chlorothiophene-2-carboxylic አሲድ |
24065-33-6 |
የካርዲዮቫስኩላር |
ሪቫሮክሳባን |
(ኤስ)-(+)-N-(2,3-ኢፖክሲፕሮፒል) phthalimide |
161596-47-0 |
የካርዲዮቫስኩላር |
ክሎፒዶግሬል |
ቲዮፊን-2-ኤታኖል |
5402-55-1 |
የካርዲዮቫስኩላር |
ክሎፒዶግሬል |
4,5,6,7-Tetrahydro-thieno[3,2-c] pyridine HCl |
28783-41-7 |
የካርዲዮቫስኩላር |
ፓትሮመር |
Methyl 2-Fluoroacrylate |
2343-89-7 |
የካርዲዮቫስኩላር |
ኢዜቲሚቤ |
(3R,4S)-4- (4- (Benzyloxy) Phenyl)-1- (4-Fluorophenyl)-3-((S)-3- (4- Fluorophenyl)-3-Hydroxypropyl) አዜቲዲን-2-አንድ |
163222-32-0 |
የካርዲዮቫስኩላር |
Fenofibrate |
Fenofibrate አሲድ: (2-[4- (4-chlorobenzoyl) phenoxy] -2-ሜቲልፕሮፒዮኒክ አሲድ) |
42017-89-0 |
የካርዲዮቫስኩላር |
ኢዶክሳባን |
ኤቲል 2- ((5-chloropyridin-2-yl) አሚኖ)-2-oxoacetate hydrochloride |
1243308-37-3 |
የካርዲዮቫስኩላር |
ኢዶክሳባን |
5-ሜቲል-4,5,6,7-tetrahydrothiazolo [5,4-c] pyridine-2-carboxylic acid hydrochloride |
720720-96-7 |
የካርዲዮቫስኩላር |
ኢዶክሳባን |
ቴርት-ቡቲል (1R,2S,5S)-2-አዚዶ-5-[(ዲሜቲኤሚኖ) ካርቦንሊል] ሳይክሎሄክሲልካርባማት ኦክሳሊክ አሲድ |
1353893-22-7 |
የካርዲዮቫስኩላር |
donorguat |
5-fluoro-1- (2-fluorobenzyl)-1H-pyrazolo [3,4-b] pyridine-3-carbonitrile |
1350653-26-7 |
የካርዲዮቫስኩላር |
Sotagliflozin |
4-Iodo-1-chloro-2- (4-ethoxybenzyl) ቤንዚን |
1103738-29-9 እ.ኤ.አ |
የስኳር በሽታ |
Sotagliflozin |
D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl-,(5S)- |
1103738-19-7 |
የስኳር በሽታ |
Sotagliflozin |
D-xylo-Pentodialdo-5,2-furanose, 1-C-[4-chloro-3-[(4-ethoxyphenyl) Methyl]phenyl]-4,5-O-(1-Methylethylidene)-,(5S) - |
1103738-30-2 |
የስኳር በሽታ |
Sotagliflozin |
5-bromo-2-chloro-4'-ethoxydiphenylmethane |
461432-23-5 |
የስኳር በሽታ |
Canagliflozin |
2- (4-FLUOROPHENYL) ቲዮፊን |
58861-48-6 እ.ኤ.አ |
የስኳር በሽታ |
Canagliflozin |
5-Bromo-2-methylbenzoic አሲድ |
79669-49-1 |
የስኳር በሽታ |